Studienserver - Medizinische Hochschule Hannover

Studies: Panobinostat for AML

ID Trial

Clinicaltrials.gov identifier

Description

A phase II study of oral single agent panobinostat in patients with refractory de novo or secondary acute myelogenous leukemia

Status